{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:11:32Z","timestamp":1790115092292,"version":"4.0.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The incidence of fungal infections has significantly increased in recent years due to the emergence of antifungal resistance. Biofilm formation is considered to be a major contributor to both the infectious diseases and to antimicrobial resistance. Consequently, biofilm-associated infections are often problematic to treat with existing therapeutics. Adhesion of <jats:italic>C. albicans<\/jats:italic> to the host surface or implanted materials followed by hyphal invasion and biofilm formation enhances <jats:italic>C. albicans<\/jats:italic> pathogenicity and virulence. Thus, developing a therapeutic agent that inhibits candidal adherence, biofilm development and morphological switching could improve clinical management of infections. The present investigation studied two emerging and alternatives strategies, namely antibiofilm and combinatorial approach, to attenuate biofilm formation and the expression of <jats:italic>Candida<\/jats:italic> virulence factors. Piperine and thymol are major bioactive components of pepper and thyme, respectively. These phytochemicals are known to possess numerous biological activities, including recently reported antibiofilm effects against <jats:italic>C. albicans<\/jats:italic>. The minimum biofilm inhibitory concentration (MBIC) of both phytochemicals was determined to be 32 \u00b5g\/ml. The phytochemical treatment of <jats:italic>Candida<\/jats:italic> biofilms using piperine and thymol revealed synergistic effects at four different combinations of concentrations, i.e. 8 and 8, 8 and 4, 8 and 2 and 4 and 8 \u00b5g\/ml. These synergistic combinations resulted in the significant reduction in adherence of <jats:italic>Candida<\/jats:italic>, hyphal extension and morphological transformation. Moreover, limited exposure of synergistic combinations controlled the hyphal elongation. Results were validated through the gene expression analysis. Results from the present investigation suggest that piperine and thymol can be synergistically employed for the treatment of biofilm-associated <jats:italic>C. albicans<\/jats:italic> infection.<\/jats:p>","DOI":"10.3389\/fcimb.2021.780545","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T04:44:40Z","timestamp":1642567480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Synergistic Interaction of Piperine and Thymol on Attenuation of the Biofilm Formation, Hyphal Morphogenesis and Phenotypic Switching in Candida albicans"],"prefix":"10.3389","volume":"11","author":[{"given":"Arumugam","family":"Priya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Nivetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunmugiah Karutha","family":"Pandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"B1","first-page":"282","article-title":"Investigation of the Potential Antibiofilm Activities of Plant Extracts","volume":"4","author":"Abraham","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.micpath.2009.10.001","article-title":"Evolution of Ergosterol Biosynthesis Inhibitors as Fungicidal Against Candida","volume":"48","author":"Ahmad","year":"2010","journal-title":"Microbial. Pathogenesis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"p.310","DOI":"10.4103\/0972-5229.132495","article-title":"Current Concepts in Combination Antibiotic Therapy for Critically Ill Patients","volume":"18","author":"Ahmed","year":"2014","journal-title":"Indian J. Crit. Care Med: Peer-Reviewed Off. Publ. Indian Soc. Crit. Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"pp.299","DOI":"10.1080\/14787210.2017.1268530","article-title":"Future Therapies Targeted Towards Eliminating Candida Biofilms and Associated Infections","volume":"15","author":"Bandara","year":"2017","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1439-0507.2007.01412.x","article-title":"Inhibitory Activity of Thymol Against the Formation and Viability of Candida Albicans Hyphae","volume":"50","author":"Braga","year":"2007","journal-title":"Mycoses"},{"key":"B6","doi-asserted-by":"publisher","first-page":"pp.472","DOI":"10.1016\/j.ijantimicag.2007.12.013","article-title":"Thymol Inhibits Candida Albicans Biofilm Formation and Mature Biofilm","volume":"31","author":"Braga","year":"2008","journal-title":"Int. J.Antimicrob. Agents"},{"key":"B7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.277.5322.105","article-title":"Control of Filament Formation in Candida Albicans by the Transcriptional Repressor TUP1","volume":"277","author":"Braun","year":"1997","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/genetics\/155.1.57","article-title":"TUP1, CPH1 and EFG1 Make Independent Contributions to Filamentation in Candida Albicans","volume":"155","author":"Braun","year":"2000","journal-title":"Genetics"},{"key":"B9","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1093\/emboj\/20.17.4753","article-title":"NRG1, a Repressor of Filamentous Growth in C. Albicans, Is Down-Regulated During Filament Induction","volume":"20","author":"Braun","year":"2001","journal-title":"EMBO J."},{"key":"B10","first-page":"520","article-title":"Combination Therapy: Synergism Between Natural Plant Extracts and Antibiotics Against Infectious Diseases","volume":"1","author":"Chanda","year":"2011","journal-title":"Microbiol. Book Ser."},{"key":"B11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1177\/00220345010800031101","article-title":"Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic In Vitro","volume":"80","author":"Chandra","year":"2001","journal-title":"J. Dental Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"pp.23","DOI":"10.1534\/genetics.111.127456","article-title":"The Regulation of Filamentous Growth in Yeast","volume":"190","author":"Cullen","year":"2012","journal-title":"Genetics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"pp.431","DOI":"10.1038\/nrmicro3061","article-title":"Ras1 as a Switch for Candida Albicans","volume":"11","author":"David","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tripleo.2009.10.006","article-title":"Susceptibility of Candida Albicans to Photodynamic Therapy in a Murine Model of Oral Candidosis","volume":"109","author":"de Oliveira Mima","year":"2010","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endodontol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"pp.835","DOI":"10.1111\/jop.13014","article-title":"The Role of Candida Albicans Candidalysin ECE1 Gene in Oral Carcinogenesis","volume":"49","author":"Engku Nasrullah Satiman","year":"2020","journal-title":"J. Oral. Pathol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1600-0714.1987.tb01494.x","article-title":"Carriage of Candida Species in the Oral Cavity in Diabetic Patients: Relationship to Glycaemic Control","volume":"16","author":"Fisher","year":"1987","journal-title":"J. Oral. Pathol. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.genrep.2020.100644","article-title":"Phylogenetic Characterization of Biofilm Forming Multidrug Resistant Candida Albicans and Non Albicans Candida Causing Vulvovaginal Candidiasis","volume":"19","author":"Krishnasamy","year":"2020","journal-title":"Gene Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/genes9090461","article-title":"Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens","volume":"9","author":"Ksiezopolska","year":"2018","journal-title":"Genes"},{"key":"B19","first-page":"pp.186","article-title":"Candida Biofilms: Antifungal Resistance and Emerging Therapeutic Options","volume":"5","author":"Kuhn","year":"2004","journal-title":"Curr. Opin. Invest Drugs (London England: 2000)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1128\/AAC.00860-09","article-title":"Patients With Long-Term Oral Carriage Harbor High-Persister Mutants of Candida Albicans","volume":"54","author":"LaFleur","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"pp.659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic Drug Combinations Tend to Improve Therapeutically Relevant Selectivity","volume":"27","author":"Leh\u00e1r","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"pp.4090","DOI":"10.1128\/JB.183.13.4090-4093.2001","article-title":"Efg1, A Morphogenetic Regulator in Candida Albicans, Is a Sequence-Specific DNA Binding Protein","volume":"183","author":"Leng","year":"2001","journal-title":"J. Bacteriol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3389\/fmicb.2020.01669","article-title":"The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design","volume":"11","author":"Le\u00f3n-Buitimea","year":"2020","journal-title":"Front. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"pp.134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous Emergence of Multidrug-Resistant Candida Auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1439-0507.2008.01542.x","article-title":"Oral Yeast Carriage in HIV-Infected and Non-Infected Populations in Rosario, Argentina","volume":"52","author":"Luque","year":"2009","journal-title":"Mycoses"},{"key":"B26","doi-asserted-by":"publisher","first-page":"pp.266","DOI":"10.1007\/s12281-010-0035-5","article-title":"Fungal Biofilms: Relevance in the Setting of Human Disease","volume":"4","author":"Martinez","year":"2010","journal-title":"Curr. Fungal Infect. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.riam.2010.03.007","article-title":"Oral Candida Carriage of Patients Attending a Dental Clinic in Braga, Portugal","volume":"27","author":"Martins","year":"2010","journal-title":"Rev. Iberoam. Micologia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1741-2358.2010.00407.x","article-title":"Prevalence and Antifungal Drug Sensitivity of Non-Albicans Candida in Oral Rinse Samples of Self-Caring Elderly","volume":"28","author":"Meurman","year":"2011","journal-title":"Gerodontology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"pp.1","DOI":"10.1038\/s41598-020-61918-y","article-title":"Global Proteomic Analysis Deciphers the Mechanism of Action of Plant Derived Oleic Acid Against Candida Albicans Virulence and Biofilm Formation","volume":"10","author":"Muthamil","year":"2020","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1128\/IAI.00480-10","article-title":"Development and Validation of an In Vivo Candida Albicans Biofilm Denture Model","volume":"78","author":"Nett","year":"2010","journal-title":"Infect. Immun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"p.e101510","DOI":"10.1371\/journal.pone.0101510","article-title":"Epidemiology and Outcomes of Invasive Candidiasis Due to non-Albicans Species of Candida in 2,496 Patients: Data From the Prospective Antifungal Therapy (PATH) Registry 2004\u20132008","volume":"9","author":"Pfaller","year":"2014","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of Invasive Candidiasis: A Persistent Public Health Problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1128\/JCM.00308-13","article-title":"Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected From 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance","volume":"51","author":"Pfaller","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3389\/fmicb.2020.00756","article-title":"Piperine Impedes Biofilm Formation and Hyphal Morphogenesis of Candida Albicans","volume":"11","author":"Priya","year":"2020","journal-title":"Front. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tripleo.2003.04.002","article-title":"Denture Stomatitis: A Role for Candida Biofilms","volume":"98","author":"Ramage","year":"2004","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endodontol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/1040841X.2011.585606","article-title":"Oral Candidosis\u2013Clinical Challenges of a Biofilm Disease","volume":"37","author":"Rautemaa","year":"2011","journal-title":"Crit. Rev. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"pp.10","DOI":"10.1099\/jmm.0.045054-0","article-title":"Candida Species: Current Epidemiology, Pathogenicity, Biofilm Formation, Natural Antifungal Products and New Therapeutic Options","volume":"62","author":"Sardi","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1439-0507.1999.tb04521.x","article-title":"Zur Taxonomie Und \u00d6kologie Der Gattung Candida: Taxonomy and Ecology of the Genus Candida","volume":"42","author":"Schauer","year":"1999","journal-title":"Mycoses"},{"key":"B39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000071711","article-title":"Systemic Diseases in Association With Microbial Species in Oral Biofilm From Elderly Requiring Care","volume":"49","author":"Senpuku","year":"2003","journal-title":"Gerontology"},{"key":"B40","first-page":"1129","article-title":"Recent Advances in the Study of Antifungal Lead Compounds With New Chemical Scaffolds","volume":"42","author":"Shao","year":"2007","journal-title":"Yao Xue Xue Bao= Acta Pharm. Sin."},{"key":"B41","doi-asserted-by":"publisher","first-page":"pp.1235","DOI":"10.2217\/fmb.09.85","article-title":"Candida Albicans Biofilm Formation and Its Clinical Consequences","volume":"4","author":"Uppuluri","year":"2009","journal-title":"Future Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1741-2358.2007.00247.x","article-title":"Denture Contamination by Yeasts in the Elderly","volume":"25","author":"Vanden Abbeele","year":"2008","journal-title":"Gerodontology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"pp.150","DOI":"10.1080\/21505594.2016.1197444","article-title":"Targeting Candida Albicans Filamentation for Antifungal Drug Development","volume":"8","author":"Vila","year":"2017","journal-title":"Virulence"},{"key":"B44","author":"Wayne","year":"2008","journal-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard \u2013 Second Edition"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.3402\/jom.v3i0.5771","article-title":"Pathogenesis and Treatment of Oral Candidosis","volume":"3","author":"Williams","year":"2011","journal-title":"J. Oral. Microbiol."},{"key":"B46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0757.2009.00338.x","article-title":"Candida Biofilms and Oral Candidosis: Treatment and Prevention","volume":"55","author":"Williams","year":"2012","journal-title":"Periodontology 2000"},{"key":"B47","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/sj.bdj.4809821","article-title":"The Aetiology, Diagnosis and Management of Denture Stomatitis","volume":"185","author":"Wilson","year":"1998","journal-title":"Br. Dental J."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.780545\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T04:44:46Z","timestamp":1642567486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.780545\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":47,"alternative-id":["10.3389\/fcimb.2021.780545"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.780545","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"article-number":"780545"}}